Works matching AU Norhammar, Anna


Results: 76
    1
    2
    3

    Lower risk of cardiovascular events and death associated with initiation of sodium‐glucose cotransporter‐2 inhibitors versus sulphonylureas: Analysis from the CVD‐REAL 2 study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2402, doi. 10.1111/dom.15092
    By:
    • Goh, Su‐Yen;
    • Kosiborod, Mikhail N.;
    • Lam, Carolyn S. P.;
    • Cavender, Matthew A.;
    • Kohsaka, Shun;
    • Norhammar, Anna;
    • Birkeland, Kåre I.;
    • Holl, Reinhard W.;
    • Mauricio, Dídac;
    • Tangri, Navdeep;
    • Shaw, Jonathan E.;
    • Thuresson, Marcus;
    • Fenici, Peter;
    • Kim, Dae Jung
    Publication type:
    Article
    4

    Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
    By:
    • Norhammar, Anna;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Haller, Hermann;
    • Linssen, Gerard C. M.;
    • Banerjee, Amitava;
    • Karasik, Avraham;
    • Mamouris, Pavlos;
    • Tangri, Navdeep;
    • Taveira‐Gomes, Tiago;
    • Maggioni, Aldo P.;
    • Botana, Manuel;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Yajima, Toshitaka;
    • Kadowaki, Takashi;
    • Birkeland, Kåre I.
    Publication type:
    Article
    5

    Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1431, doi. 10.1111/dom.14356
    By:
    • Lam, Carolyn S. P.;
    • Karasik, Avraham;
    • Melzer‐Cohen, Cheli;
    • Cavender, Matthew A.;
    • Kohsaka, Shun;
    • Norhammar, Anna;
    • Thuresson, Marcus;
    • Chen, Hungta;
    • Wittbrodt, Eric;
    • Fenici, Peter;
    • Kosiborod, Mikhail
    Publication type:
    Article
    6

    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Banerjee, Amitava;
    • Kim, Dae Jung;
    • Norhammar, Anna;
    • Eriksson, Jan W.;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Ha, Kyoung Hwa;
    • Kossack, Nils;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    7

    Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Haller, Hermann;
    • Linssen, Gerard C.M.;
    • Banerjee, Amitava;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Garal‐Pantaler, Elena;
    • Overbeek, Jetty;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Admission Plasma Glucose.

    Published in:
    Diabetes Care, 1999, v. 22, n. 11, p. 1827, doi. 10.2337/diacare.22.11.1827
    By:
    • Norhammar, Anna M.;
    • Ryden, Ears;
    • Malmberg, Klas
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50